Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Hazebroek

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
JACC. Cardiovascular Imaging|June 9, 2022
Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated CardiomyopathyAnne G Raafs, Jacqueline L Vos, Michiel T H M Henkens, et al.
Journal of the American College of Cardiology|September 19, 2015
Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy: Applying the MOGE(S) ClassificationMark R Hazebroek, Suzanne Moors, Robert Dennert, et al.
Circulation. Heart Failure|March 16, 2018
Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated CardiomyopathyMark R Hazebroek, Ingrid Krapels, Job Verdonschot, et al.
Circulation. Heart Failure|December 21, 2018
Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated CardiomyopathyJob A J Verdonschot, Mark R Hazebroek, Ping Wang, et al.
Journal of Cardiac Failure|May 25, 2023
Left Atrial Function in Patients with Titin CardiomyopathyMichiel T H M Henkens, Anne G Raafs, Tim Vanloon, et al.
Circulation. Genomic and Precision Medicine|January 22, 2025
Family Screening in Patients With Dilated and Arrhythmogenic Cardiomyopathy: The Road Toward Gene-Specific RecommendationsSophie L V M Stroeks, Steven Muller, Nina J Beelen, et al.
Journal of the American Heart Association|March 7, 2022
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy PatientsAnne G Raafs, Andrea Boscutti, Michiel T H M Henkens, et al.
Circulation. Genomic and Precision Medicine|September 4, 2020
Implications of Genetic Testing in Dilated CardiomyopathyJob A J Verdonschot, Mark R Hazebroek, Ingrid P C Krapels, et al.
ESC Heart Failure|March 18, 2022
The HFA-PEFF score identifies 'early-HFpEF' phenogroups associated with distinct biomarker profilesMichiel T H M Henkens, Anne-Mar van Ommen, Sharon Remmelzwaal, et al.
Journal of Clinical Medicine|September 9, 2023
Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal StudyAnne G Raafs, Bouke P Adriaans, Michiel T H M Henkens, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
JACC. Cardiovascular Imaging|June 9, 2022
Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated CardiomyopathyAnne G Raafs, Jacqueline L Vos, Michiel T H M Henkens, et al.
Journal of the American College of Cardiology|September 19, 2015
Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy: Applying the MOGE(S) ClassificationMark R Hazebroek, Suzanne Moors, Robert Dennert, et al.
Circulation. Heart Failure|March 16, 2018
Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated CardiomyopathyMark R Hazebroek, Ingrid Krapels, Job Verdonschot, et al.
Circulation. Heart Failure|December 21, 2018
Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated CardiomyopathyJob A J Verdonschot, Mark R Hazebroek, Ping Wang, et al.
Journal of Cardiac Failure|May 25, 2023
Left Atrial Function in Patients with Titin CardiomyopathyMichiel T H M Henkens, Anne G Raafs, Tim Vanloon, et al.
Circulation. Genomic and Precision Medicine|January 22, 2025
Family Screening in Patients With Dilated and Arrhythmogenic Cardiomyopathy: The Road Toward Gene-Specific RecommendationsSophie L V M Stroeks, Steven Muller, Nina J Beelen, et al.
Journal of the American Heart Association|March 7, 2022
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy PatientsAnne G Raafs, Andrea Boscutti, Michiel T H M Henkens, et al.
Circulation. Genomic and Precision Medicine|September 4, 2020
Implications of Genetic Testing in Dilated CardiomyopathyJob A J Verdonschot, Mark R Hazebroek, Ingrid P C Krapels, et al.
ESC Heart Failure|March 18, 2022
The HFA-PEFF score identifies 'early-HFpEF' phenogroups associated with distinct biomarker profilesMichiel T H M Henkens, Anne-Mar van Ommen, Sharon Remmelzwaal, et al.
Journal of Clinical Medicine|September 9, 2023
Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal StudyAnne G Raafs, Bouke P Adriaans, Michiel T H M Henkens, et al.
Pageof 4